Concentrations of oestradiol-17β and testosterone were estimated in peripheral venous plasma and testicular venous plasma of adult male rats before and after administration of human chorionic gonadotrophin (HCG) or follicle-stimulating hormone (FSH). The concentration of oestradiol-17β in peripheral plasma, as measured with a radioimmunological technique, was 2·0 ± 0·9 (s.d.) pg/ml (n = 12). Peripheral testosterone concentrations were 2·4 ± 1·8 (s.d.) ng/ml (n = 21). Concentrations of oestradiol-17β and testosterone in testicular venous plasma were significantly higher than those in peripheral plasma. After intravenous administration of HCG (100 i.u.), oestradiol-17β and testosterone concentrations in testicular venous plasma increased significantly. After prolonged s.c. administration of HCG (5 days) the concentration of oestradiol-17β in testicular venous plasma did not change significantly, although the concentration of testosterone increased more than ten times. Intravenous administration of HCG after 5 days of pretreatment with HCG caused a significant increase in oestradiol-17β concentrations in testicular venous plasma. The increase in testosterone concentration was not significant under these conditions.
Intravenous administration of FSH did not change oestradiol-17β or testosterone concentrations in testicular venous plasma.
Journal of Endocrinology is committed to supporting researchers in demonstrating the impact of their articles published in the journal.
The two types of article metrics we measure are (i) more traditional full-text views and pdf downloads, and (ii) Altmetric data, which shows the wider impact of articles in a range of non-traditional sources, such as social media.
More information is on the Reasons to publish page.
Sept 2018 onwards | Past Year | Past 30 Days | |
---|---|---|---|
Full Text Views | 2 | 2 | 0 |
PDF Downloads | 2 | 1 | 0 |